20,000
Participants
Start Date
July 1, 2022
Primary Completion Date
July 1, 2025
Study Completion Date
December 31, 2025
The study did not involve intervention in the patient's treatment regimen
This study is based on a prospective database platform to register the occurrence, treatment and prognosis of breast cancer in China, so there is no clear exposure factor. This study was a prospective cohort study, which did not intervene in exposure factors, but only assessed the occurrence, treatment, and prognosis of breast cancer in China.
RECRUITING
Cancer Hospital/ Institute, Fudan University, Shanghai
Fudan University
OTHER